DeepVerge (LON:DVRG) is very chuffed with its £10mln fund raiser. CEO Gerard Brandon tells Proactive London that the money will allow the company to maintain its current steady growth as well as build scale globally using lab support worldwide. With significant institutional participants, it's a real vote of confidence for the medical technology and services company and Brandon is excited now for the rapid roll out of its pathogen detection of SARS-Covid-2 in waste water systems following interest from governments and health care systems all over the world. In particular, DeepVerge said the money would allow for the acceleration of Labskin Services: expand Skin Trust Club; sales at Modern Water and be used for for working capital. News here to on the China Resources deal, which represents a huge potential client base following talks with the Chinese government's state-owned concern.
DeepVerge's milestone £10mln funding round is 100% up on 2019 placing
